Coccidioidomycosis where you least expect it
- 1 Pulmonary Medicine, KS Hegde Medical Academy, Mangalore, Karnataka, India
- 2 Pathology, KS Hegde Medical Academy, Mangalore, Karnataka, India
- Correspondence to Dr Nandu Nair; drnn.official@gmail.com
Abstract
An elderly man without history of travel presented with complaints of intermittent fever for 2 months, cough with scanty expectoration for 15 days and history of weight loss of 5 kg in 1 year. The chest X-ray and CT scan of the thorax showed dispersed centrilobular nodules and patchy subpleural consolidation in both lungs with mediastinal lymphadenopathy. He underwent bronchoscopy and bronchoalveolar lavage culture grew Pseudomonas aeruginosa. He was prescribed antibiotics based on culture sensitivity; however, patient continued to have symptoms. All relevant blood investigations were within normal limits. He underwent CT-guided biopsy of the right lung lesion during which clearing of the radio-opacities present in the initial CT scan and appearance of fresh lesions in different locations were observed. Migratory shadows were suspected. Fine-needle aspiration cytology showed features suggestive of coccidioidomycosis for which antifungals were started. After 1 month, he improved symptomatically and chest X-ray showed clearance of shadows.
Background
Coccidioidomycosis is a fungal infection which is predominantly found in the hot arid states of Texas, Nevada, New Mexico, Arizona and large parts of central and southern California in the southwestern United States. Risk factors include residency or travel in endemic areas, immunocompromised state secondary to uncontrolled diabetes, HIV, cancer, advanced age, organ transplantation and taking immunosuppressive drugs for any cause. In India, three cases of pulmonary coccidioidomycosis have been reported from different parts of the country, namely Verghese et al in Chennai, Savio et al in Andhra Pradesh and Oberoi et al in New Delhi. In all three cases, the patient had a history of travel to or from endemic areas in the USA. Common clinical presentations include fever, cough, fatigue, breathlessness, night sweats, muscle or join pains and headache. This case reports outlines an Indian patient with absolutely no travel history to any endemic area, get diagnosed with coccidioidomycosis.
Case presentation
An elderly man, farmer with no known comorbidities with no significant travel history, presented to the pulmonary medicine out-patient unit with complaints of intermittent episodes of fever for 2 months and cough with scanty expectoration for 15 days. It was associated with an evening rise in temperature. Cough was associated with scanty, thick, mucoid expectoration. Patient also had history of weight loss of about 5 kg in the last 1 year. There was no history of haemoptysis, foul-smelling sputum, breathlessness or orthopnea. He was referred to a local hospital, where radiography in the form of chest X-ray (figure 1) and CT scan of the thorax was done and showed ‘centrilobular nodules in all the lobes of both the lungs, patchy consolidation in subpleural location of right upper lobe, right middle lobe and bilateral lower lobes and mediastinal lymphadenopathy’ (figure 2). The patient underwent bronchoscopy and bronchoalveolar lavage (BAL) was sent for further analysis. BAL culture grew pseudomonas aeruginosa but did not detect mycobacterium tuberculosis (MTb) in the cartridge based nucleic acid amplification test (CBNAAT). He was prescribed tablet ciprofloxacin 500 mg two times per day for a week based on culture sensitivity pattern; however, the patient continued to have symptoms. The patient was hence referred to us for further evaluation and management. All relevant blood investigations were done and were found to be within normal limits. The patient was planned for image-guided biopsy of the right lung lesion. However, during the procedure, it was observed that there was clearing of the radio-opacities, which were present in the initial CT scan and appearance of fresh lesions in different locations. Since there was a 3-week lag between the initial CT and the current one, migratory shadows were suspected. Fine-needle aspiration cytology (FNAC) showed features suggestive of coccidioidomycosis (figures 3 and 4). The patient was started on tablet fluconazole 400 mg once a day and has since shown improvement in the form of reduction in symptoms as well as clearance of shadows on repeat chest X-ray after 1 month (figure 5).
Chest X-ray shows bilateral mid-zone hazy opacities.

CT thorax shows consolidation and surrounding ground-glass opacities in the left lower lobe.

Microphotograph of CT-guided fine-needle aspiration cytology showing thick-walled yeast-like fungal structures measuring around 75–100 microns (morphologically mimicking coccidioidomycosis) against the background of mixed inflammatory cells and haemorrhage (MGG stain × 45×).

Microphotograph of CT-guided fine-needle aspiration cytology showing thick-walled yeast-like fungal structures measuring around 75–100 microns (morphologically mimicking coccidioidomycosis) with ruptured endospores (MGG stain × 45×).

Chest X-ray shows clearing of the patches 1 month after starting treatment.

Investigations
CT scan of the thorax showed ‘Centrilobular nodules in all the lobes of both the lungs, patchy consolidation in subpleural location of right upper lobe, right middle lobe and bilateral lower lobes and mediastinal lymphadenopathy’ (figure 2).
BAL culture grew pseudomonas aeruginosa but did not detect mycobacterium tuberculosis in the CBNAAT.
All relevant blood investigations were done and were found to be within normal limits.
CT-guided FNAC of the lesion showed features suggestive of coccidioidomycosis (figures 3 and 4).
Differential diagnosis
Possibility of lung malignancy was considered on presentation in view of fever of 2 months, cough with scanty expectoration of 15 days associated with weight loss. CT did not show any lesions suggestive of malignancy; however, centrilobular nodules were seen and possibility of tuberculosis was considered. BAL CBNAAT for MTb was found to be negative. FNAC of the lung lesion was done and showed features suggestive of coccidioidomycosis. The patient showed improvement in both symptoms and chest X-ray after 1 month of treatment with antifungals, hence supporting the diagnosis of pulmonary coccidioidomycosis.
Treatment
Patient was treated with ciprofloxacin at an outside hospital after which he did not show much improvement. He was started on fluconazole after acquiring the diagnosis of coccidioidomycosis and has shown improvement after a month.
Outcome and follow-up
Patient showed clinical improvement as well as improvement of shadows on repeat chest X-ray after a month following fluconazole therapy (figure 5). He is now able to go to work as well as do his daily activities without much difficulty.
Discussion
‘Pulmonary migratory infiltrates’ is a term used to describe pulmonary infiltrates that seem to recurrently appear and resolve over a short period of time (days to weeks) with new lesions appearing elsewhere in the lungs. In this way, it presents a picture of the infiltrates appearing to move or ‘migrate’ through the lungs over a period of time.
In pulmonary migratory infiltrates, the differential diagnoses comprises cryptogenic organising pneumonia, parasitic infections, recurrent aspiration, Churg-Strauss syndrome and chronic eosinophilic pneumonia. Case reports show that it has also been seen in mycoplasma pneumonia, allergic broncho-pulmonary aspergillosis (ABPA) and pulmonary coccidioidomycosis.
Coccidioidomycosis is a fungal infection. It was first discovered to be affecting humans in Argentina in 1892.
The hot, arid deserts in Texas, Nevada, New Mexico, Arizona and large parts of central and southern California in the southwestern United States form the life zone of Coccidioides spp. Cases have also been recorded in areas and countries far removed from the endemic region. These locations include Poland,1 Japan,2 3 Hong Kong,4 the Netherlands,5 China6 and states in the northeastern United States.7
In India, three cases of pulmonary coccidioidomycosis have been reported from different parts of the country, namely Verghese et al in Chennai,8 Savio et al 9 in Andhra Pradesh and Oberoi et al in New Delhi.10 In all three cases, the patient had a history of travel to or from endemic areas in the USA.
In our case report, the patient is a farmer who lives on a daily wage who has never moved out of the geographical area.
He had significant exposure to soil dust and developed his symptoms quite gradually. In non-endemic areas, common causative agents should be ruled out first before suspecting atypical organisms.
In this patient, most organisms were ruled out with BAL culture, AFB and CBNAAT and hence atypical organism was suspected.
Following this, our patient underwent a CT-guided FNAC which revealed features morphologically mimicking coccidioidomycosis. Furthermore, patient’s symptoms and radiological lesions improved after just a month of fluconazole.
Patient’s perspective
I was very unwell for a long time. I visited many hospitals in the vicinity and was given treatment but I continued to feel worse every day. Finally, I was referred to this tertiary care hospital where the doctor told me to do a needle test and was told to have fungal infection. I was started on tablets for the same and I started feeling better in a week and the doctors have told me that my X-ray has also become better.
Learning points
-
This case report shows that invasive sampling should be done when patient is not responding to usual treatment.
-
Suspecting coccidioidomycosis is important if patient reports with chronic persistent symptoms, more so once infections with more common organisms have been effectively ruled out.
-
It is important to keep clinical suspicion for coccidioidomycosis even in non-endemic areas.
Ethics statements
Patient consent for publication
Acknowledgments
I would like to thank all the personnel involved in management of this patient including the doctors, my colleagues, interns and nurses who sincerely put in effort in the best interests of the patient.
Footnotes
-
Twitter @nandanbaikunje
-
Contributors NN: Worked on managing the patient as well as typing out this case report. NB: Checked and corrected the manuscript. SY: Reported cytology. NN, NB, GBH: Participated in patient management.
-
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
-
Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.
-
Competing interests None declared.
-
Provenance and peer review Not commissioned; externally peer reviewed.
- © BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.
References
Use of this content is subject to our disclaimer